rotation.to
Following this device: dark.
Free account
rotation.to
Sign in / Request free access
Appearance
Following this device: dark.
Drag a card by its title · ⚙ to size, swap or remove

Who

Jennifer Burstein

Director

Company insider

Files Form 4 as: Director, Stoke Therapeutics; Senior VP of Finance, Loxo Oncology.

Every Form 4 they filed

In numbers

Trades disclosed
145
Buys
0
Sells
22
Bought
$0
Sold
$4.2M
Companies
2
Companies where not an officer
1
First trade
1 May 2015
Last trade
3 Jun 2026
Last filed
5 Jun 2026

Companies traded

Where they are an officer
Loxo OncologyOfficer · last 15 Feb 20190 buys · 22 sells
Everywhere else they filed: board seats, 10% stakes, other companies
STOK Stoke TherapeuticsDirector · Biotechnology · last 3 Jun 20260 buys · 0 sells

Activity over time

1 Nov 2024 – 1 Oct 2026
101Nov 24May 25Nov 25Apr 26Oct 26

Buys above the line, sells below, each month.

Every trade

TradedCompanyWhatAmount
3 Jun 2026filed 5 Jun 2026STOK Stoke Therapeuticsoption or derivative · BiotechnologySEC FORM 4 Code A—17,786 at $0.00filing
3 Jun 2026filed 5 Jun 2026STOK Stoke Therapeuticsoption or derivative · BiotechnologySEC FORM 4 Code A—17,786 at $0.00filing
3 Jun 2025filed 4 Jun 2025STOK Stoke Therapeuticsoption or derivative · BiotechnologySEC FORM 4 Code A—29,747 at $0.00filing
5 Jun 2024filed 7 Jun 2024STOK Stoke Therapeuticsoption or derivative · BiotechnologySEC FORM 4 Code A—7,639 at $0.00filing
13 Jun 2023filed 15 Jun 2023STOK Stoke Therapeuticsoption or derivative · BiotechnologySEC FORM 4 Code A—19,441 at $0.00filing
7 Jun 2022filed 8 Jun 2022STOK Stoke Therapeuticsoption or derivative · BiotechnologySEC FORM 4 Code A—21,000 at $0.00filing
8 Jun 2021filed 25 Jun 2021STOK Stoke Therapeuticsoption or derivative · BiotechnologySEC FORM 4 Code A—11,650 at $0.00filing
3 Jun 2020filed 5 Jun 2020STOK Stoke Therapeuticsoption or derivative · BiotechnologySEC FORM 4 Code A—14,777 at $0.00filing
10 Sep 2019filed 12 Sep 2019STOK Stoke Therapeuticsoption or derivative · BiotechnologySEC FORM 4 Code A—29,555 at $0.00filing
15 Feb 2019filed 15 Feb 2019Loxo Oncologyoption or derivativeSEC FORM 4 Code D$4.1M17,500 at $235.00filing
15 Feb 2019filed 15 Feb 2019Loxo Oncologyoption or derivativeSEC FORM 4 Code D$6.6M28,000 at $235.00filing
15 Feb 2019filed 15 Feb 2019Loxo Oncologyoption or derivativeSEC FORM 4 Code D$6.6M28,000 at $235.00filing
15 Feb 2019filed 15 Feb 2019Loxo Oncologyoption or derivativeSEC FORM 4 Code D$2.8M12,000 at $235.00filing
15 Feb 2019filed 15 Feb 2019Loxo Oncologyoption or derivativeSEC FORM 4 Code D$9.4M40,000 at $235.00filing
15 Feb 2019filed 15 Feb 2019Loxo Oncologyoption or derivativeSEC FORM 4 Code D$4.7M20,000 at $235.00filing
2 Jan 2019filed 2 Jan 2019Loxo Oncologyoption or derivativeSEC FORM 4 Code A—20,000 at $0.00filing
11 Dec 2018filed 12 Dec 2018Loxo Oncologyoption or derivativeSEC FORM 4 Code M—1,250 at $0.00filing
11 Dec 2018filed 12 Dec 2018Loxo OncologySEC FORM 4 Code M$14K1,250 at $11.35filing
11 Dec 2018filed 12 Dec 2018Loxo OncologySEC FORM 4 Sold$27K200 at $135.69filing
11 Dec 2018filed 12 Dec 2018Loxo OncologySEC FORM 4 Sold$80K587 at $136.98filing

News

No headline names them, or the companies they trade most, lately.

Sectors

Not placed22

Buys in green, sells in red, by the company’s sector.

Related people

Nobody else traded the same names lately.